Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: Integrated analysis from the CANVAS Program and CREDENCE trial

Nephrology Dialysis Transplantation(2023)

引用 0|浏览2
暂无评分
摘要
Diabetes, Obesity and MetabolismAccepted Articles RESEARCH LETTEROpen Access Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: integrated analysis from the CANVAS Program and CREDENCE trial Tae Won Yi, Tae Won Yi The George Institute for Global Health, UNSW Sydney, Sydney, Australia Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, CanadaSearch for more papers by this authorMichelle M.Y. Wong, Michelle M.Y. Wong Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, CanadaSearch for more papers by this authorBrendon L. Neuen, Brendon L. Neuen orcid.org/0000-0001-9276-8380 The George Institute for Global Health, UNSW Sydney, Sydney, Australia Royal North Shore Hospital, Sydney, AustraliaSearch for more papers by this authorClare Arnott, Clare Arnott orcid.org/0000-0001-9370-9913 The George Institute for Global Health, UNSW Sydney, Sydney, Australia Faculty of Medicine, UNSW Sydney, Sydney, Australia Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia Sydney Medical School, University of Sydney, AustraliaSearch for more papers by this authorPaul Poirier, Paul Poirier Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, CanadaSearch for more papers by this authorJochen Seufert, Jochen Seufert orcid.org/0000-0001-5654-7310 Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanySearch for more papers by this authorApril Slee, April Slee New Arch Consulting, Seattle, WA, USASearch for more papers by this authorWally Rapattoni, Wally Rapattoni orcid.org/0000-0001-6400-982X Janssen, Inc., Toronto, ON, CanadaSearch for more papers by this authorFernando G. Ang, Fernando G. Ang Janssen, Inc., Toronto, ON, CanadaSearch for more papers by this authorDavid C. Wheeler, David C. Wheeler The George Institute for Global Health, UNSW Sydney, Sydney, Australia Centre for Nephrology, University College London, London, UKSearch for more papers by this authorKenneth W. Mahaffey, Kenneth W. Mahaffey Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USASearch for more papers by this authorVlado Perkovic, Vlado Perkovic The George Institute for Global Health, UNSW Sydney, Sydney, Australia Royal North Shore Hospital, Sydney, Australia Faculty of Medicine, UNSW Sydney, Sydney, AustraliaSearch for more papers by this authorAdeera Levin, Corresponding Author Adeera Levin alevin@providencehealth.bc.ca orcid.org/0000-0003-2438-8401 Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada Correspondence (s): Adeera Levin Email: alevin@providencehealth.bc.caSearch for more papers by this author Tae Won Yi, Tae Won Yi The George Institute for Global Health, UNSW Sydney, Sydney, Australia Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, CanadaSearch for more papers by this authorMichelle M.Y. Wong, Michelle M.Y. Wong Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, CanadaSearch for more papers by this authorBrendon L. Neuen, Brendon L. Neuen orcid.org/0000-0001-9276-8380 The George Institute for Global Health, UNSW Sydney, Sydney, Australia Royal North Shore Hospital, Sydney, AustraliaSearch for more papers by this authorClare Arnott, Clare Arnott orcid.org/0000-0001-9370-9913 The George Institute for Global Health, UNSW Sydney, Sydney, Australia Faculty of Medicine, UNSW Sydney, Sydney, Australia Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia Sydney Medical School, University of Sydney, AustraliaSearch for more papers by this authorPaul Poirier, Paul Poirier Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, QC, CanadaSearch for more papers by this authorJochen Seufert, Jochen Seufert orcid.org/0000-0001-5654-7310 Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanySearch for more papers by this authorApril Slee, April Slee New Arch Consulting, Seattle, WA, USASearch for more papers by this authorWally Rapattoni, Wally Rapattoni orcid.org/0000-0001-6400-982X Janssen, Inc., Toronto, ON, CanadaSearch for more papers by this authorFernando G. Ang, Fernando G. Ang Janssen, Inc., Toronto, ON, CanadaSearch for more papers by this authorDavid C. Wheeler, David C. Wheeler The George Institute for Global Health, UNSW Sydney, Sydney, Australia Centre for Nephrology, University College London, London, UKSearch for more papers by this authorKenneth W. Mahaffey, Kenneth W. Mahaffey Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USASearch for more papers by this authorVlado Perkovic, Vlado Perkovic The George Institute for Global Health, UNSW Sydney, Sydney, Australia Royal North Shore Hospital, Sydney, Australia Faculty of Medicine, UNSW Sydney, Sydney, AustraliaSearch for more papers by this authorAdeera Levin, Corresponding Author Adeera Levin alevin@providencehealth.bc.ca orcid.org/0000-0003-2438-8401 Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada Correspondence (s): Adeera Levin Email: alevin@providencehealth.bc.caSearch for more papers by this author First published: 27 March 2023 https://doi.org/10.1111/dom.15065 This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1111/dom.15065. AboutPDF ToolsExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Accepted ArticlesAccepted, unedited articles published online and citable. The final edited and typeset version of record will appear in the future. RelatedInformation
更多
查看译文
关键词
canagliflozin,chronic kidney disease,peripheral arterial disease,kidney events
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要